IMURAN

This brand name is authorized in Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug IMURAN contains one active pharmaceutical ingredient (API):

1 Azathioprine
UNII MRK240IY2L - AZATHIOPRINE

Azathioprine is a pro-drug of 6-mercaptopurine (6-MP). 6-MP is inactive but acts as a purine antagonist and requires cellular uptake and intracellular anabolism to thioguanine nucleotides (TGNs) for immunosuppression. The TGNs and other metabolites (e.g. 6-methyl-mecaptopurine ribonucleotides) inhibit de novo purine synthesis and purine nucleotide interconversions.

Read about Azathioprine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
IMURAN Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L04AX01 Azathioprine L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2687K, 2688L
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 505612040035714, 505613110039803
Country: CA Health Products and Food Branch Identifier(s): 00004596, 02244895
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29909-07-11
Country: EE Ravimiamet Identifier(s): 1004500, 1678158, 1865099
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 20186, 20202, 27698, 381404
Country: HK Department of Health Drug Office Identifier(s): 03804, 30975
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-628872163
Country: IE Health Products Regulatory Authority Identifier(s): 28762, 28847, 28894, 84612, 84625, 84638, 84662
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 1107, 2457
Country: JP 医薬品医療機器総合機構 Identifier(s): 3999005F1059
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1000951, 1085691, 1085796
Country: MT Medicines Authority Identifier(s): AA565/76001
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 69062
Country: NL Z-Index G-Standaard, PRK Identifier(s): 5681
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 16562, 337, 338
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100030481, 100030498
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W60846001
Country: SG Health Sciences Authority Identifier(s): 02082P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699874080090, 8699874080106
Country: US FDA, National Drug Code Identifier(s): 54766-590
Country: ZA Health Products Regulatory Authority Identifier(s): D/26/98

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.